Ross L. Levine, MD

Ross L. Levine, MD

I am a physician-scientist with a specific interest in the genetics and therapy of myeloid malignancies, including the myeloproliferative neoplasms polycythemia vera, essential thrombocytosis, and primary myelofibrosis.

See my page on the Human Oncology and Pathogenesis Program for details of my laboratory research program.

Location

New York City

Appointments for New Patients

212-639-5279

Phone

646-888-2767

Clinical Expertise

Leukemias, Myeloproliferative Neoplasms

Languages Spoken

English

Education

MD, Johns Hopkins School of Medicine

Residencies

Massachusetts General Hospital

Fellowships

Dana-Farber Cancer Institute; Brigham and Women’s Hospital/Harvard Medical School

Board Certifications

Internal Medicine; Hematology; Medical Oncology

See My Colleagues in:

Department of Medicine›Leukemia Service

Topics Recommended by Ross L. Levine

Human Oncology & Pathogenesis Program

At Work: Physician-Scientist Ross Levine

Ross L. Levine: Publications

Related Multimedia See all »

Integrated Genetic Profiling in Acute Myelogenous Leukemia

(For Healthcare Professionals)

Leukemia Q&A

Improving Quality of Life for Leukemia Patients

Diagnosing Leukemia

cancer (KAN-ser)

A term for diseases in which abnormal cells divide without control and can invade nearby tissues. Cancer cells can also spread to other parts of the body through the blood and lymph systems. There are several main types of cancer. Carcinoma is a cancer that begins in the skin or in tissues that line or cover internal organs. Sarcoma is a cancer that begins in bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissue. Leukemia is a cancer that starts in blood-forming tissue such as the bone marrow, and causes large numbers of abnormal blood cells to be produced and enter the blood. Lymphoma and multiple myeloma are cancers that begin in the cells of the immune system. Central nervous system cancers are cancers that begin in the tissues of the brain and spinal cord. Also called malignancy.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

essential thrombocytosis (eh-SENT-shul THROM-boh-sy-TOH-sis)

An increased number of thrombocytes (platelets) in the blood, without a known cause. Also called essential thrombocythemia.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

genetics (jeh-NEH-tix)

The study of genes and heredity. Heredity is the passing of genetic information and traits (such as eye color and an increased chance of getting a certain disease) from parents to offspring.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

L

A measure of volume for a liquid, using the metric system. One L is equal to 1,000 cubic centimeters (cc), 1,000 milliliters (mm), or 1.0567 quarts (qt). Also called liter.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

medicine (MEH-dih-sin)

Refers to the practices and procedures used for the prevention, treatment, or relief of symptoms of a diseases or abnormal conditions. This term may also refer to a legal drug used for the same purpose.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

myelofibrosis (MY-eh-loh-fy-BROH-sis)

A disorder in which the bone marrow is replaced by fibrous tissue.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

myeloid (MY-eh-loyd)

Having to do with or resembling the bone marrow. May also refer to certain types of hematopoietic (blood-forming) cells found in the bone marrow. Sometimes used as a synonym for myelogenous; for example, acute myeloid leukemia and acute myelogenous leukemia are the same disease.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

oncology (on-KAH-loh-jee)

The study of cancer.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

polycythemia vera (PAH-lee-sy-THEE-mee-uh VAYR-uh)

A disease in which there are too many red blood cells in the bone marrow and blood, causing the blood to thicken. The number of white blood cells and platelets may also increase. The extra blood cells may collect in the spleen and cause it to become enlarged. They may also cause bleeding problems and make clots form in blood vessels.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

therapy (THAYR-uh-pee)

Treatment.

Source: The National Cancer Institute's Dictionary of Cancer Terms
(http://www.cancer.gov/dictionary)

View Ross L. Levine's laboratory research.